Kinderhook Takes Enhabit Private in $13.80 Per Share Deal
Event summary
- Enhabit acquired by Kinderhook Industries for $13.80 per share in cash, delisting from NYSE effective immediately.
- Transaction completed on May 15, 2026, making Enhabit a private company.
- Barb Jacobsmeyer remains CEO, with Kinderhook providing additional resources for growth and clinical capabilities.
- Kinderhook highlights Enhabit's patient-centric culture and strong market position as key investment factors.
The big picture
Kinderhook's acquisition of Enhabit reflects the private equity firm's focus on middle-market healthcare services with defensible niches. The deal underscores the ongoing consolidation in home health and hospice care, as private investors seek to capitalize on demographic trends favoring in-home medical services. With over $11 billion in committed capital, Kinderhook aims to enhance Enhabit's clinical offerings and geographic footprint.
What we're watching
- Growth Strategy
- How Kinderhook's resources will accelerate Enhabit's expansion in home health and hospice services.
- Operational Integration
- Whether the transition to private ownership will streamline decision-making and clinical capabilities.
- Market Positioning
- The pace at which Enhabit can leverage Kinderhook's network to strengthen its niche market positioning.
Related topics